Chlamydia pneumoniae and Coronary Artery Disease: The Antibiotic Trials

Higgins, John P.
March 2003
Mayo Clinic Proceedings;Mar2003, Vol. 78 Issue 3, p321
Academic Journal
Discusses the potential role of Chlamydia pneumoniae infection in atherosclerosis. Randomized clinical trials of antichlamydial antibiotics in patients with coronary heart disease; Detection of infection; Four classes of antibiotics against infection; Specific factors that may link Chlamydia pneumoniae infection and coronary artery disease.


Related Articles

  • Detection of Chlamydia pneumoniae within Peripheral Blood Monocytes of Patients with Unstable Angina or Myocardial Infarction. Maass, Matthias; Jahn, Jurgen; Gieffers, Jens; Dalhoff, Klaus; Katus, Hugo A.; Solbach, Werner // Journal of Infectious Diseases;6/15/2000 Supplement 3, Vol. 181, pS449 

    Presents a study that uses polymerase chain reaction detection of chlamydial DNA applied to cells from patients with angiographically identified unstable angina or acute myocardial infarction. Presence of Chlamydia pneumoniae in monocytes/macrophages of a significant proportion of persons with...

  • Growth in Vascular Cells and Cytokine Production by Chlamydia pneumoniae. Gaydos, Charlotte A. // Journal of Infectious Diseases;6/15/2000 Supplement 3, Vol. 181, pS473 

    Proposes the need for studies to learn the relationship between productive infection and persistence, the ability of Chlamydia pneumoniae to affect the immune response, and the potential for C. pneumoniae to influence atheromatous lesions. Proposed pathogenesis of C. pneumoniae in...

  • Chlamydia pneumoniae Infection and Incident Coronary Heart Disease. Nieto, F. Javier; Folsom, Aaron R.; Sorlie, Paul D.; Grayston, J.Thomas; Wang, San-Pin; Chambless, Lloyd E. // American Journal of Epidemiology;1999, Vol. 150 Issue 2, p149 

    Pathologic findings and cross-sectional epidemiologic studies suggest that past infection with Chlamydia pneumoniae is associated with clinical and subclinical atherosclerotic disease, although evidence from prospective studies is still scarce. The association between chronic infection by C....

  • Chlamydia pneumoniae e doença aterosclerótica. Sehnem, Luciele; Bodanese, Luiz Carlos; Repetto, Giuseppe; Staub, Henrique Luiz // Scientia Medica;Sep2010, Vol. 20 Issue 3, p250 

    Aims: To study the etiopathogenic role of Chlamydia pneumoniae infection in the atherosclerotic disease, in vitro studies and animal models involving Chlamydia pneumonia and atheromatosis were reviewed, as well as clinical assays that analyzed the association between the pathogen and...

  • Preventing Coronary Disease with Antibiotics. Wellbery, Caroline // American Family Physician;4/15/2004, Vol. 69 Issue 8, p2010 

    Presents the results of a study which assessed the effect of antibiotic treatment in the prevention of coronary disease in patients with previous myocardial infarction and evidence of Chlamydia pneumoniae infection. Methodology; Types of a non-coronary atherosclerotic event; Precautions on the...

  • A Review of Macrolide Treatment of Atherosclerosis and Abdominal Aortic Aneurysms. Lindholt, Jes S.; Stovring, Jette; Andersen, Paul Lehm; Henneberg, Eskild W.; Ostergaard, Lars // Current Drug Targets - Infectious Disorders;Mar2003, Vol. 3 Issue 1, p55 

    Seroepidemiological studies have shown an association between Chlamydia pneumoniae and atherosclerosis, the risk of acute myocardial infarction and abdominal aortic aneurysms (AAA). Several studies have detected C. pneumoniae in atherosclerotic lesions from coronary and carotid arteries, in AAA,...

  • Association between past infection with Chlamydia pneumoniae and body mass index, low-density lipoprotein particle size and fasting insulin. Dart, A.M.; Martin, J.L.; Kay, S. // International Journal of Obesity & Related Metabolic Disorders;Apr2002, Vol. 26 Issue 4, p464 

    Investigates the association between Chlamydia pneumoniae infection history and coronary heart disease (CHD) risk factors. Body mass index; Prevalence of seropositivity for subjects with and without CHD; Fasting insulin level; Low-density-lipoprotein particles.

  • Antibiotic Treatment of Chlamydia pneumoniae after Acute Coronary Syndrome. Cannon, Christopher P.; Braunwald, Eugene; McCabe, Carolyn H.; Grayston, J. Thomas; Muhlestein, Brent; Giugliano, Robert P.; Cairns, Richard; Skene, Allan M. // New England Journal of Medicine;4/21/2005, Vol. 352 Issue 16, p1646 

    Background: Chlamydia pneumoniae has been found within atherosclerotic plaques, and elevated titers of antibody to this organism have been linked to a higher risk of coronary events. Pilot studies have suggested that antibiotic treatment may reduce the risk of cardiovascular events. Methods: We...

  • Chlamydia pneumoniae Infection Accelerates the Progression of Atherosclerosis in Apoliopoprotein E-Deficient Mice. Moazed, Teresa C.; Campbell, Lee Ann; Rosenfeld, Michael E.; Grayston, J. Thomas; Cho-chou Kuo // Journal of Infectious Diseases;7/1/99, Vol. 180 Issue 1, p238 

    Analyzes whether there is a causal relationship between Chlamydia pneumoniae infection and atherosclerosis. Effects of chronic infection with C. pneumoniae on the development of atherosclerosis; Differences in total plasma cholesterol levels between the study and control groups; Progression of...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics